La radiactividad es un fenómeno natural y artificial que ha despertado gran interés y preocupación debido a su impacto en los tejidos vivos. Desde los primeros descubrimientos de la radiactividad hasta los avances científicos actuales, se ha profundizado en la comprensi&o …
Efectos de la radiactividad en los tejidos vivos Read More »
AlzeCure Pharma AB announced that another scientific article has been published on the phase I clinical results supporting the continued development of the lead drug candidate NeuroRestore ACD856.
bit.bio, the company coding human cells for novel cures, announces the first project within a multi-year collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research to prioritise the development and delivery of a range of human cell products relevant to Parkinson’s disease.
En la historia de la ingeniería, Etienne Lenoir se destaca como un visionario pionero cuyas innovaciones sentaron las bases para la revolución del motor de combustión. A través de su ingenio y determinación, Lenoir dejó una marca indeleble en la historia de …
Etienne Lenoir: El ingeniero detrás de la revolución del motor de combustión Read More »
El autoconsumo doméstico emerge como una solución prometedora para reducir la dependencia de fuentes de energía convencionales y mitigar el impacto ambiental. Examinemos los elementos principales necesarios para establecer una instalación de autoconsumo doméstica, …
Los elementos esenciales para una instalación de autoconsumo doméstica Read More »
CARBIOS announced that CARBIOS Active, its enzymatic solution for the biodegradation of PLA, is included in the U.S. Food and Drug Administration Inventory of Effective Food Contact Substances with the Assigned Food Contact Notification 2325, effective since 29 February 2024.
Nicox SA, an international ophthalmology company, provided details of poster presentations highlighting data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting, one of the key scientific events in vision research, which was held on February 29th to March 3rd, 2024 in Huntington Beach, CA, United States.
The Board of Directors of Sandoz announced that it proposes Mathai Mammen, M.D., Ph.D., and Michael Rechsteiner for election to its Board of Directors at the company’s Annual General Meeting on April 30, 2024.
Sandoz announces nominations to the Board of Directors and leadership change Read More »
AnHeart Therapeutics and Innovent Biologics, Inc. announced that the Center for Drug Evaluation of China’s National Medical Products Administration has accepted a second New Drug Application for taletrectinib, a next-generation ROS1 tyrosine kinase inhibitor.
Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, confirms that the first patient has been enrolled and treated in its Phase 2 clinical trial of CYP-001 in high-risk acute graft versus host disease.
